C Olier

520 total citations
21 papers, 124 citations indexed

About

C Olier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, C Olier has authored 21 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in C Olier's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). C Olier is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). C Olier collaborates with scholars based in Spain, Australia and Russia. C Olier's co-authors include Juan Antonio Carrillo, Nuria Romero-Laorden, Carlos Jara, Guillermo Gervasini, Xabier Mielgo-Rubio, Rafael López Castro, J. Rubio, Elia Pérez‐Fernández, Isabel Blancas and Belén Sádaba and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

C Olier

21 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Olier Spain	6	72	34	32	24	15	21	124
David Soong United States	6	30 0.4×	42 1.2×	21 0.7×	13 0.5×	20 1.3×	9	115
Kristin A. Rand United States	5	34 0.5×	44 1.3×	52 1.6×	35 1.5×	14 0.9×	6	145
Roi Tschernichovsky Israel	5	33 0.5×	24 0.7×	24 0.8×	22 0.9×	8 0.5×	17	101
Stephan Spahn Germany	6	57 0.8×	47 1.4×	59 1.8×	10 0.4×	15 1.0×	15	160
Georgina L. Eden Australia	5	43 0.6×	70 2.1×	36 1.1×	15 0.6×	7 0.5×	8	133
Rita Leporati Italy	7	140 1.9×	21 0.6×	46 1.4×	17 0.7×	9 0.6×	16	188
Katarzyna Pawińska-Wąsikowska Poland	7	35 0.5×	20 0.6×	10 0.3×	10 0.4×	8 0.5×	15	93
Matěj Kočík Czechia	5	40 0.6×	32 0.9×	22 0.7×	6 0.3×	39 2.6×	10	100
Maria Giakoumopoulos United States	6	34 0.5×	67 2.0×	28 0.9×	10 0.4×	38 2.5×	11	133
Maddalena Marchesi Italy	8	33 0.5×	51 1.5×	13 0.4×	16 0.7×	20 1.3×	17	158

Countries citing papers authored by C Olier

Since Specialization

Citations

This map shows the geographic impact of C Olier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Olier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Olier more than expected).

Fields of papers citing papers by C Olier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Olier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Olier. The network helps show where C Olier may publish in the future.

Co-authorship network of co-authors of C Olier

This figure shows the co-authorship network connecting the top 25 collaborators of C Olier. A scholar is included among the top collaborators of C Olier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Olier. C Olier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mira, José Joaquín, Pura Ballester, C Olier, et al.. (2023). Safe Care and Medication Intake Provided by Caregivers at Home: Reality Care Study Protocol. Healthcare. 11(15). 2190–2190. 2 indexed citations

Olier, C, et al.. (2023). #4934 HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY WITH CISPLATIN INCREASES THE RISK OF ACUTE KIDNEY INJURY COMPARED TO CONVENTIONAL INTRAPERITONEAL CISPLATIN. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

Monte-Millán, Marı́a del, Yolanda Jerez, Marta Roche-Molina, et al.. (2022). 85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study. Annals of Oncology. 33. S160–S161. 2 indexed citations

Blancas, Isabel, et al.. (2021). Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer. Scientific Reports. 11(1). 4274–4274. 7 indexed citations

Doménech, Marta, Carlos Mesía, Anna Esteve, et al.. (2021). Long-term results of the GEINO 1401 TRIAL: Randomizing patients to stop or to continue temozolomide until 12 cycles.. Journal of Clinical Oncology. 39(15_suppl). 2013–2013. 1 indexed citations

Bianchini, Giampaolo, Chanel E. Smart, Mauro Mansutti, et al.. (2020). Modulation by treatment of tumor infiltrating lymphocytes (TILs) and PDL1 expression in triple-negative breast cancer in the ETNA trial.. Journal of Clinical Oncology. 38(15_suppl). 555–555. 3 indexed citations

Manso, Luís, Juan Ignacio Delgado Mingorance, Noelia Martínez-Jáñez, et al.. (2019). Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study. The Breast Journal. 25(2). 219–225. 5 indexed citations

Mielgo-Rubio, Xabier, Carlos Aguado, María Sereno, et al.. (2019). P1.04-16 Early Antibiotic Use Affects the Efficacy of First Line Immunotherapy in Lung Cancer Patients but Route of Administration Seems to be Decisive. Journal of Thoracic Oncology. 14(10). S445–S445. 4 indexed citations

Balañá, Carmen, Sonia Del Barco Berrón, José Muñoz-Langa, et al.. (2019). Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.. Journal of Clinical Oncology. 37(15_suppl). 2001–2001. 6 indexed citations

10.

Mielgo-Rubio, Xabier, et al.. (2018). MA10.01 Antibiotic Use and PD-1 Inhibitors: Shorter Survival in Lung Cancer, Especially When Given Intravenously. Type of Infection Also Matters. Journal of Thoracic Oncology. 13(10). S389–S389. 26 indexed citations

11.

Mielgo-Rubio, Xabier, et al.. (2018). P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer. Journal of Thoracic Oncology. 13(10). S488–S489. 2 indexed citations

12.

Mielgo-Rubio, Xabier, Rafael López Castro, J. Rubio, et al.. (2018). Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients. Annals of Oncology. 29. viii510–viii510. 2 indexed citations

13.

Gervasini, Guillermo, et al.. (2016). Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. British Journal of Clinical Pharmacology. 83(3). 562–571. 25 indexed citations

14.

Manso, Luís, Fernando Moreno, Beatriz Castelo, et al.. (2015). Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer. Current Oncology. 22(2). 51–60. 15 indexed citations

15.

Olier, C, et al.. (2011). Primary melanoma of the vagina. A clinical case. Journal of the Turkish-German Gynecological Association. 12(1). 50–52. 3 indexed citations

16.

Espinós, J., C Olier, José Manuel Aramendía, et al.. (2008). Efficacy of the combination of irinotecan and bevacizumab in heavely pretreated metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 12001–12001. 2 indexed citations

17.

Perez‐Gracia, José Luis, José M. López-Picazo, C Olier, et al.. (2007). Nuevos tratamientos para el carcinoma renal. Anales del Sistema Sanitario de Navarra. 30(3). 393–403. 1 indexed citations

18.

Gúrpide, Alfonso, Belén Sádaba, Salvador Martín‐Algarra, et al.. (2007). Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients Treated with Platinum-Based Chemotherapy. The Oncologist. 12(9). 1151–1155. 11 indexed citations

19.

Viteri, Santiago, Javier Rodríguez, María González Cao, et al.. (2006). Preliminary results for the combination of docetaxel, oxaliplatin and capecitabine as a first-line treatment for metastatic oesophagogastric cancer. Journal of Clinical Oncology. 24(18_suppl). 14076–14076. 1 indexed citations

20.

Olier, C, et al.. (1985). [Ureteral invagination caused by a fibroepithelial polyp of the ureter. Apropos of a case].. PubMed. 19(6). 403–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact